Status:
RECRUITING
Heparin Solution Versus Anti-adhesion Barrier Gel for Intrauterine Adhesions Prevention After Operative Hysteroscopy
Lead Sponsor:
Nadezhda Women's Health Hospital
Conditions:
Intrauterine Adhesion
Eligibility:
FEMALE
25-50 years
Phase:
NA
Brief Summary
The aim of this study is to compare the efficacy of intrauterine application of heparin solution to the use of hyaluronic acid barrier gel for the prevention of intrauterine adhesion formation after o...
Detailed Description
In this trial the investigators aim to evaluate and compare the effect of heparin solution to anti-adhesive hyaluronic barrier gel administration immediately after operative hysteroscopy on post-surgi...
Eligibility Criteria
Inclusion
- female sex
- indication for operative hysteroscopy including one or more of the following:
- infertility,
- irregular bleeding,
- oligo-/amenorrhea,
- Asherman syndrome,
- G0-G3 fibroids,
- dysmorphic uterus.
Exclusion
- ongoing pregnancy,
- genital cancer,
- pelvic inflammatory disease,
- excessive uterine bleeding.
Key Trial Info
Start Date :
February 14 2022
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
February 28 2026
Estimated Enrollment :
100 Patients enrolled
Trial Details
Trial ID
NCT05257213
Start Date
February 14 2022
End Date
February 28 2026
Last Update
May 21 2025
Active Locations (2)
Enter a location and click search to find clinical trials sorted by distance.
1
Nadezhda Women's Health Hospital
Sofia, Sofia, Bulgaria, 1330
2
Nadezhda Women's Health Hospital
Sofia, Bulgaria, 1373